References
- National Heart, Lung, and Blood Institute. Guidelines for the diagnosis and management of asthma: National Asthma Education Program. Expert Panel Report. J Allergy Clin Immunol 1991: 88(3 Pt 2): 425–534
- Djukanovic R, Roche WR, Wilson JW, et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990: 142(2): 434–57
- Barnes PJ. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J Allergy Clin Immunol 1989: 83(6): 1013–26
- Liu MC, Bleecker ER, Lichtenstein LM, et al. Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma. Am Rev Respir Dis 1990: 142(1): 126–32
- Beasley R, Roche WR, Roberts JA, et al. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989: 139(3): 806–17
- Laitinen LA, Heino M, Laitinen A, et al. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985: 131(4): 599–606
- Cockcroft DW. Therapy for airway inflammation in asthma. J Allergy Clin Immunol 1991: 87(5): 914–9
- Gaddy JN, Busse WW. A fresh look at the mechanisms and treatment of asthma. Contemp Intern Med 1990: 2(2): 74–84
- Rainey DK. Pre-clinical research on nedocromil sodium. Presented before Investigators Meeting. Chicago: 1991 Jun 27
- Barnes PJ. A new approach to the treatment of asthma. N Engl J Med 1989: 321(22): 1517–27
- Sears MR, Taylor DR, Print CG, et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990: 336(8728): 1391–6
- Spitzer WO, Suissa S, Ernst P, et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 1992: 326(8): 501–6
- Bierman CW, Williams PV. Therapeutic monitoring of theophylline: rationale and current status. Clin Pharmacokinet 1989: 17(6): 377–84
- Skinner MH. Adverse reactions and interactions with theophylline. Drug Saf 1990: 5(4): 275–85
- Kuzemko JA. Twenty years of sodium cromoglycate treatment: a short review. Respir Med 1989: 83(Suppl A): 11–6
- König P. The role of inhaled steroids in the treatment of asthma. Respir Med 1989: 83 (Suppl A): 43–7
- Hollman GA, Allen DB. Overt glucocorticoid excess due to inhaled corticosteroid therapy. Pediatrics 1988: 81(3): 452–5
- Littlewood JM, Johnson AW, Edwards PA, et al. Growth retardation in asthmatic children treated with inhaled beclomethasone dipropionate. (Letter) Lancet 1988: 1(8577): 115–6
- König P. Inhaled corticosteroids: their present and future role in the management of asthma. J Allergy Clin Immunol 1988: 82(2): 297–306
- Teelucksingh S, Padfield PL, Tibi L, et al. Inhaled corticosteroids, bone formation, and osteocalcin. (Letter) Lancet 1991: 338(8758): 60–1
- Reid DM, Nicoll JJ, Smith MA, et al. Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. BMJ 1986: 293(6560): 1463–6
- Reed CE. Aerosol steroids as primary treatment of mild asthma. (Editorial) N Engl J Med 1991: 325(6): 425–6